Identification of Potential Biomarkers of Response to Peptide Immunotherapy for Ragweed Allergy

NCT01361412 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Ragweed Allergy

Interventions

BIOLOGICAL: ToleroMune Ragweed
BIOLOGICAL: Placebo

Sponsor

Circassia Limited

Collaborators

[object Object]
[object Object]